Morgan Stanley Neuronetics, Inc. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Neuronetics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 646,040 shares of STIM stock, worth $2.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

646,040

Previous 71,270 806.47%

Holding current value

$2.04 Million

Previous $262,000 760.31%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$3.32 - $4.65 $1.91 Million - $2.67 Million	574,770 Added 806.47%	646,040 $2.25 Million
Q1 2025 May 15, 2025	BUY	$1.49 - $5.54 $105,015 - $390,459	70,480 Added 8921.52%	71,270 $262,000
Q2 2024 Oct 17, 2024	SELL	$1.73 - $4.81 $23,277 - $64,718	-13,455 Reduced 94.45%	790 $1,000
Q2 2024 Aug 14, 2024	SELL	$1.73 - $4.81 $23,277 - $64,718	-13,455 Reduced 94.45%	790 $1,000
Q1 2024 Oct 17, 2024	BUY	$2.68 - $4.8 $36,059 - $64,584	13,455 Added 1703.16%	14,245 $67,000
Q1 2024 Aug 16, 2024	BUY	$2.68 - $4.8 $30,578 - $54,768	11,410 Added 402.47%	14,245 $67,000
Q1 2024 May 15, 2024	BUY	$2.68 - $4.8 $30,578 - $54,768	11,410 Added 402.47%	14,245 $67,000
Q4 2023 Aug 16, 2024	BUY	$1.05 - $2.9 $2,147 - $5,930	2,045 Added 258.86%	2,835 $8,000
Q4 2023 Feb 13, 2024	BUY	$1.05 - $2.9 $191 - $527	182 Added 6.86%	2,835 $8,000
Q3 2023 Nov 15, 2023	SELL	$1.29 - $2.22 $22,353 - $38,468	-17,328 Reduced 86.72%	2,653 $3,000
Q2 2023 Aug 14, 2023	SELL	$2.07 - $2.92 $276,624 - $390,214	-133,635 Reduced 86.99%	19,981 $42,000
Q1 2023 May 15, 2023	SELL	$2.81 - $6.71 $800,408 - $1.91 Million	-284,843 Reduced 64.96%	153,616 $447,000
Q4 2022 Feb 14, 2023	BUY	$2.74 - $6.87 $1.1 Million - $2.76 Million	401,126 Added 1074.45%	438,459 $3.01 Million
Q3 2022 Nov 14, 2022	SELL	$2.35 - $4.66 $63,372 - $125,666	-26,967 Reduced 41.94%	37,333 $119,000
Q2 2022 Oct 27, 2022	BUY	$2.09 - $3.71 $108,673 - $192,908	51,997 Added 422.64%	64,300 $208,000
Q2 2022 Aug 15, 2022	BUY	$2.09 - $3.71 $108,673 - $192,908	51,997 Added 422.64%	64,300 $208,000
Q1 2022 Oct 27, 2022	SELL	$2.84 - $4.52 $147,671 - $235,026	-51,997 Reduced 80.87%	12,303 $37,000
Q1 2022 May 13, 2022	BUY	$2.84 - $4.52 $11,683 - $18,595	4,114 Added 50.24%	12,303 $37,000
Q4 2021 Feb 14, 2022	SELL	$3.87 - $6.59 $525,441 - $894,744	-135,773 Reduced 94.31%	8,189 $35,000
Q3 2021 Nov 15, 2021	BUY	$6.22 - $15.54 $895,443 - $2.24 Million	143,962 New	143,962 $944,000

Others Institutions Holding STIM

# of Institutions

Shares Held

18.6M

Call Options Held

49.6K

Put Options Held

78.8K

View Full List

About Neuronetics, Inc.

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $85.1M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

More about STIM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account